CHICAGO, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced a long-term strategic partnership with Prime Ledger LLC ("Prime Ledger"), a leading provider of blockchain infrastructure services and digital asset treasury management. This multi-phase agreement is centered on a comprehensive digital transformation of Cosmos Health's financial operations, including participating in the management of its $300,000,000 treasury facility and the tokenization of high-value intellectual property (IP).

Marvell Technology Inc. (NASDAQ: MRVL) posted better-than-expected earnings for the third quarter and also announced the acquisition of Celestial AI on Tuesday.

Wells Fargo analyst Michael Turrin initiates coverage on the stock at Overweight with a $280 price target.

Marvell Technology Inc (NASDAQ: MRVL) just put a very loud stake in the ground: revenue could reach roughly $10 billion next year, CEO Matt Murphy said in the company's third quarter earnings call Q&A, and the market's reaction feels like it's still absorbing the size of that ambition. What sounded like cautious guidance quickly morphed into something closer to a multi-year AI supercycle roadmap.

Transaction in Own Shares 03 December, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company') announces that on 03 December, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 03/12/2025 736,192 28.1400 27.8850 28.0185 LSE GBP 03/12/2025 - - - - Chi-X (CXE) GBP 03/12/2025 - - - - BATS (BXE) GBP 03/12/2025 731,646 32.1650 31.8050 …

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit?

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit?

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit?

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Synopsys, Inc. (“Synopsys” or the “Company”) (NASDAQ: SNPS) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit?

LOS ANGELES, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises DeFi Technologies, Inc., (“DeFi” or the "Company") (NASDAQ: DEFT) investors off a class action on behalf of investors that bought securities between May 12, 2025 and November 14, 2025, inclusive (the “Class Period”). DeFi investors have until January 30, 2026 to file a lead plaintiff motion.

ATLANTA, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT) complied with federal securities laws. On November 12, 2025, Ardent announced third quarter 2025 results, revealing, among other things, that “[d]uring the third quarter, a change in accounting estimate resulting from a modification to the technique used to estimate the collectability of accounts receivable and new information provided by recently completed hindsight evaluations of historical collection trends resulted in a decrease in revenue of $43 million.” Following this news, the price of the Company's stock dropped.

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds James Hardie Industries plc (“James Hardie” or the “Company”) (NYSE: JHX) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit?

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Baxter International Inc. (“Baxter” or the “Company”) (NYSE: BAX) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit?

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds CarMax, Inc. (“CarMax” or the “Company”) (NYSE: KMX) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit?

MOLINE, Ill. , Dec. 3, 2025 /PRNewswire/ -- The Deere & Company (NYSE: DE) Board of Directors today declared a quarterly dividend of $1.62 per share payable February 9, 2026, to stockholders of record on December 31, 2025.

Mattel, Inc. (MAT) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript

YieldMax NVDA Option Income Strategy ETF offers a high-risk, high-yield income play, best suited as a complement to a long NVDA position. NVDY's synthetic option-writing strategy delivers ~100% yield but exposes investors to persistent share price erosion and underperformance versus NVDA. Weekly distributions are attractive but highly variable; capital erosion risk is significant, especially if NVDA's price growth slows or reverses.

Dollar Tree, Inc. (NASDAQ:DLTR) shares moved higher as the discount retailer's third quarter earnings beat Wall Street expectations as consumers continue to favor value. For the quarter ended November 1, adjusted earnings per share (EPS) came in at $1.21, exceeding the consensus estimate of $1.09.

Microsoft Corp (NASDAQ:MSFT) shares fell 2.1% on Wednesday morning after a report suggested the company has lowered expectations for sales of its newer artificial intelligence products among business customers. The Information reported that Microsoft has reduced growth goals for AI software, citing two salespeople in the Azure cloud unit.

The payments company expects its branded checkout service to grow more slowly in the fourth quarter. Other segments look brighter.